Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Immunosuppression by OKT3--induction of programmed cell death (apoptosis) as a possible mechanism of action.

× No keyword cloud information.

8 in total

1. OKT3 and IL-2 treatment for purging of the latent HIV-1 reservoir in vivo results in selective long-lasting CD4+ T cell depletion.

Authors: R M van Praag; J M Prins; M T Roos; P T Schellekens; I J Ten Berge; S L Yong; H Schuitemaker; A J Eerenberg; S Jurriaans; F de Wolf; C H Fox; J Goudsmit; F Miedema; J M Lange
Journal: J Clin Immunol Date: 2001-05 Impact factor: 8.317

Review 2. Muromonab CD3: a reappraisal of its pharmacology and use as prophylaxis of solid organ transplant rejection.

Authors: M I Wilde; K L Goa
Journal: Drugs Date: 1996-05 Impact factor: 9.546

3. Induction of active tolerance and involvement of CD1d-restricted natural killer T cells in anti-CD3 F(ab')2 treatment-reversed new-onset diabetes in nonobese diabetic mice.

Authors: Guojiang Chen; Gencheng Han; Jianan Wang; Renxi Wang; Ruonan Xu; Beifen Shen; Jiahua Qian; Yan Li
Journal: Am J Pathol Date: 2008-03-18 Impact factor: 4.307

4. Polyclonal T cell elimination by prolonged immunostimulation in an experimental model.

Authors: F Galdiero; M Galdiero; I Nuzzo; M Vitiello; C Bentivoglio; C Romano-Carratelli
Journal: Clin Exp Immunol Date: 1997-11 Impact factor: 4.330

Review 5. The role of activation-induced cell death in the differentiation of T-helper-cell subsets.

Authors: Arthur I Roberts; Satish Devadas; Xiaoren Zhang; Liying Zhang; Achsah Keegan; Kristy Greeneltch; Jennifer Solomon; Lixin Wei; Jyoti Das; Erwei Sun; Catherine Liu; Zengrong Yuan; Jian-Nian Zhou; Yufang Shi
Journal: Immunol Res Date: 2003 Impact factor: 2.829

Immunosuppression by OKT3--induction of programmed cell death (apoptosis) as a possible mechanism of action.

1. OKT3 and IL-2 treatment for purging of the latent HIV-1 reservoir in vivo results in selective long-lasting CD4+ T cell depletion.

Review 2. Muromonab CD3: a reappraisal of its pharmacology and use as prophylaxis of solid organ transplant rejection.

3. Induction of active tolerance and involvement of CD1d-restricted natural killer T cells in anti-CD3 F(ab')2 treatment-reversed new-onset diabetes in nonobese diabetic mice.

4. Polyclonal T cell elimination by prolonged immunostimulation in an experimental model.

Review 5. The role of activation-induced cell death in the differentiation of T-helper-cell subsets.

6. In vitro induction of regulatory T cells by anti-CD3 antibody in humans.

7. Activation of human T cells by FcR nonbinding anti-CD3 mAb, hOKT3gamma1(Ala-Ala).

8. Reduction of Cell Surface T-Cell Receptor by Non-Mitogenic CD3 Antibody to Mitigate Murine Lupus.